Stockscreener 앱 받기
4.64
3.80%
0.17
전일 마감가:
$4.47
열려 있는:
$4.47
하루 거래량:
482.85K
Relative Volume:
1.32
시가총액:
$293.62M
수익:
$2.72M
순이익/손실:
$-85.08M
주가수익비율:
-2.4041
EPS:
-1.93
순현금흐름:
$-70.93M
1주 성능:
-2.32%
1개월 성능:
+57.82%
6개월 성능:
+498.32%
1년 성능:
+325.69%
1일 변동 폭
$4.36
$4.68
1주일 범위
$4.09
$4.804
52주 변동 폭
$0.6922
$4.89
셰턱랩스 Stock (STTK) Company Profile
명칭
Shattuck Labs Inc
전화
512-900-4690
주소
500 W. 5TH STREET, AUSTIN
STTK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.64 | 282.86M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
셰턱랩스 Stock (STTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | 개시 | Wedbush | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Outperform |
| 2024-10-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-02 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-31 | 개시 | BTIG Research | Buy |
| 2022-06-01 | 개시 | Citigroup | Buy |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2021-01-11 | 개시 | Evercore ISI | Outperform |
| 2020-11-03 | 개시 | Citigroup | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Needham | Buy |
모두보기
셰턱랩스 주식(STTK)의 최신 뉴스
Resistance Check: Is Shattuck Labs Inc stock a value trapQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Update - Defense World
Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK) - Seeking Alpha
Shattuck Labs (STTK) Price Target Increased by 16.67% to 4.76 - Nasdaq
Shattuck Labs Files $200 Million Mixed Shelf - marketscreener.com
Pullback Watch: Why is Comtech Telecommunications Corp stock going upWeekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
CEO Change: How Shattuck Labs Inc stock reacts to Fed rate cuts2025 Risk Factors & Long Hold Capital Preservation Plans - Bộ Nội Vụ
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
How interest rate cuts could boost Shattuck Labs Inc. stockEarnings Performance Report & Free Technical Confirmation Trade Alerts - Улправда
Will Shattuck Labs Inc. stock gain from lower inflationLong Run Comfort Guide & lightweight options for faster days - Улправда
How Shattuck Labs Inc. stock reacts to global recession fearsJuly 2025 Final Week & AI Enhanced Execution Alerts - Улправда
Can Shattuck Labs Inc. stock attract ESG capital inflowsWeekly Gains Report & Stepwise Entry and Exit Trade Signals - Улправда
Is Shattuck Labs Inc. stock a top pick in earnings seasonBull Run & Weekly Stock Breakout Alerts - Улправда
Individual Investors Are Shattuck Labs, Inc.'s (NASDAQ:STTK) Biggest Owners and Were Rewarded After Market Cap Rose by US$73m Last Week - 富途牛牛
Shattuck Labs (NASDAQ:STTK) Trading 20.6% Higher – Time to Buy? - Defense World
Does Shattuck Labs Inc. stock trade at a discount to peersRisk Adjusted Returns & You’ve Never Seen Stock Picks Like These - Улправда
Why Shattuck Labs stock soared in December - MSN
Why Madrigal Pharmaceuticals Stock Slumped on Tuesday - AOL.com
Shattuck Labs (STTK): Citigroup Maintains Neutral Rating, Raises Price Target | STTK Stock News - GuruFocus
Shattuck Labs (STTK) Stock Soars 74% Following Analyst Upgrade to Buy - Intellectia AI
Why Shattuck Labs Stock Soared in December - Yahoo Finance
Several Insiders Invested In Shattuck Labs Flagging Positive News - Yahoo Finance
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - MSN
Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - AOL.com
Shattuck Labs Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Why Shattuck Labs Inc. stock is a must watch in 2025Portfolio Update Report & Daily Volume Surge Trade Alerts - Улправда
How Shattuck Labs Inc. stock performs in rate cut cyclesMarket Activity Recap & Daily Profit Maximizing Trade Tips - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Shattuck Labs, Inc. (NASDAQ:STTK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3%Time to Sell? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3% – Time to Sell? - Defense World
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 - Investing News Network
Shattuck Labs announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Shattuck Labs (NASDAQ: STTK) grants 206K inducement options under Rule 5635(c)(4) - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: Shattuck Labs Inc (STTK) - setenews.com
Shattuck Labs (STTK) price target increased by 33.33% to 4.08 - MSN
Shattuck Labs (STTK) Price Target Increased by 33.33% to 4.08 - Nasdaq
What's Next For Shattuck Labs? SL-325 And Bispecific Antibody Programs - RTTNews
Why Shattuck Labs Inc. stock remains undervalued2025 Dividend Review & Weekly Top Performers Watchlists - Newser
STTK: Receptor-targeted TL1A therapy shows promise for safer, more effective treatment and rapid development - TradingView
Shattuck Labs, Inc. (STTK) Slides 8% in Pre-market: Without a Clear Catalyst - Stocks Telegraph
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - AOL.com
It is Poised to be a Bull Market for Shattuck Labs Inc (STTK) - setenews.com
Why hedge funds are buying Shattuck Labs Inc. stockM&A Rumor & Stock Portfolio Risk Control - Newser
HC Wainwright & Co. Upgrades Shattuck Labs (STTK) - Nasdaq
Shattuck's Bowel Disease Treatment Looks Promising: AnalystShattuck Labs (NASDAQ:STTK) - Benzinga
Shattuck Labs Shares Rise After HC Wainwright Upgrade - marketscreener.com
STTK: Shattuck Labs Receives 'Buy' Upgrade from HC Wainwright & Co. | STTK Stock News - GuruFocus
셰턱랩스 (STTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
셰턱랩스 주식 (STTK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ashiya Mona | Director |
Aug 25 '25 |
Buy |
0.87 |
6,306,127 |
5,471,826 |
5,255,106 |
4.73%
0.92%
자본화:
|
볼륨(24시간):